These discrepancies observed in the different studies may be related to different factors such as the confounding factors resulting from the co-existence of other autoimmune diseases in RA patients, methods of leptin measuring, small sample sizes, different treatments given, etc. [98]. This evidence concerns the gene LEP and rheumatoid arthritis.